Medicamen Biotech Announcements
Compliance Certifcate under Reg 74 (5) of SEBI (DP) Regulation , 2018
16 Apr, 2026 | 04:36pm • Source: BSE
Announcement Under Regulation 30 (LODR) - Intimation Regarding Incorrect Event Disply On NSDL Portal
Intimation regarding Incorrent Event Display on NSDL Portal
06 Apr, 2026 | 04:21pm • Source: BSE
Medicamen Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
30 Mar, 2026 | 01:09pm • Source: NSE
Intimation of Closure of Trading Window - March 2026
30 Mar, 2026 | 12:52pm • Source: BSE
The company has on 27.01.2026 received a cautionery letter (Email) from NSE for observations reported by the Secretarial Auditor in ASCR for FY ended...
21 Feb, 2026 | 04:47pm • Source: BSE
Corrigendum- Intimation regarding completion of term of Independent Directorship of Mr Harish Pande and Mr Arun Kumar
18 Feb, 2026 | 06:01pm • Source: BSE
Announcement under Regulation 30 (LODR) - Newspaper Publication
16 Feb, 2026 | 05:53pm • Source: BSE
Pursuant to Regulation 30 of the SEBI (Listing Obligatons and Disclosure Requirements) Regulations 2025, the Company hereby informs that Mr. Harish Pande and Mr. Arun...
13 Feb, 2026 | 04:25pm • Source: BSE
Unaudited Financial Results for the quarter ended on December 31, 2025
13 Feb, 2026 | 03:59pm • Source: BSE
Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and...
04 Feb, 2026 | 03:49pm • Source: BSE
Compliance- Certificate under Reg 74 (5) of SEBI (DP) Regulations 2018
16 Jan, 2026 | 12:37pm • Source: BSE
Announcement under Regulation 30 (LODR) - EU approval for product registration of Paracetamol from Danish Medicine Authority with XGX Pharma - Denmark
07 Jan, 2026 | 03:59pm • Source: BSE
Closure of Trading Window - For declaration of unaudited financial results for the quarter ended on December 31, 2025
26 Dec, 2025 | 12:39pm • Source: BSE
Financial Results for the quarter and half year ended on September 30, 2025
14 Nov, 2025 | 04:22pm • Source: BSE
Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and...
05 Nov, 2025 | 04:37pm • Source: BSE
Outcome of the 32nd Annual General Meeting of the Company.
26 Sep, 2025 | 02:41pm • Source: BSE
Please find enclosed herewith the revised intimation for Book Closure for the purpose of 32nd Annual general Meeting of the Company.
04 Sep, 2025 | 05:15pm • Source: BSE
Please find enclosed herewith the intimation for Book Closure for the purpose of the 32nd Annual General Meeting of the Company.
04 Sep, 2025 | 11:38am • Source: BSE
Pursuant to Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations''), please find enclosed...
03 Sep, 2025 | 06:28pm • Source: BSE
Announcement under Regulation 30 (LODR) - Newspaper Publication
13 Aug, 2025 | 01:52pm • Source: BSE